eGene Responds to Growing Interest in its High Performance Genetic Analyzer
News Feb 10, 2006
eGene Inc. has announced that as a result of growing interest from potential users of the company’s product line, the company is actively seeking distributors in North America.
"We have been receiving a number of inquiries about our system as a result of more and more uses for genetic testing," said Ming Liu, president and CEO of eGene, Inc.
"In order to respond to those inquiries, we believe it would be to our benefit to establish a network of distributors."
eGene’s high performance genetic analyzer, HDA-GT12™ was introduced in mid 2004 and to date the company has shipped 130 units to research laboratories worldwide, where the units are currently used for a variety of genotyping applications.
These applications include microsatellites, STR, AFLP, RFLP and RNA quality check in human, animal, plant and bacterial samples.
An automated multi-capillary electrophoresis system, eGene’s HDA-GT12 is a bench-type system that uses a fluorescence mechanism for nucleic acid detection.
A consumable multi-capillary gel cartridge used with the system can automatically inject and analyze 12 strip samples simultaneously in 10 minutes or a 96-well plate in one hour.
The HDA-GT12 Genetic Analyzer is designed to overcome the bottlenecks of slab-gel electrophoresis, thus improving the workflow and increasing the productivity of medium-to-high-throughput laboratories.
The BioCalculator™ software from eGene Inc. controls the operation of the instrument and data analysis.
The BioCalculator software is designed to give researchers the flexibility to choose electropherogram and gel-view formats for genetic identification and characterization analysis.
Bioethics Council Rules Heritable Genome Editing "Ethically Acceptable" In Certain CircumstancesNews
A leading UK bioethics advisory body has weighed in on the debate around human genetic modification, concluding that heritable genome editing – modifying the DNA of an egg, sperm or embryo with changes that will be passed on to future generations – could be ‘morally permissible’ in humans, provided key ethical tests are met.
Genetic Factors Leading to Rare Bone Fusion Disorder IdentifiedNews
Genome sequencing establishes multiple genes responsible for a rare condition that cause bone fusionREAD MORE
Hay Fever Risk Genes Overlap with Autoimmune DiseaseNews
In a large international study involving almost 900,000 participants, researchers from the University of Copenhagen and COPSAC have found new risk genes for hay fever. It is the largest genetic study so far on this type of allergy, which affects millions of people around the world.READ MORE